ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for STOK

Stock NameStoke Therapeutics Inc
TickerSTOK(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS86150R1077
LEI549300RD25SS2DIJHJ67

Show aggregate STOK holdings

News associated with STOK

Notable Wednesday Option Activity: AAPL, STOK, Z
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Apple Inc (Symbol: AAPL), where a total volume of 543,181 contracts has been traded thus far today, a contract volume which is representative of approximately 54 - 2025-09-17 16:17:22
7 Biotech Stocks Trading At 52-Week Highs - Can The Rally Continue?
(RTTNews) - Patience is a virtue - important in all aspects of life, and especially crucial when it comes to investing. As trading expert Steve Burns once said, "Much of our trading comes down to a battle between our patience and our impulses." - 2025-09-15 03:55:16
Analysts Set Stoke Therapeutics, Inc. (NASDAQ:STOK) PT at $25.57
Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report) has earned an average rating of “Buy” from the nine ratings firms that are covering the stock, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 12-month target price among […] - 2025-08-22 03:12:53
Stoke Therapeutics (NASDAQ:STOK) Shares Gap Up on Better-Than-Expected Earnings
Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report)’s share price gapped up before the market opened on Wednesday following a better than expected earnings announcement. The stock had previously closed at $13.53, but opened at $14.89. Stoke Therapeutics shares last traded at $15.14, with a volume of 236,029 shares changing hands. The company reported ($0.40) […] - 2025-08-15 02:34:48
40,181 Shares in Stoke Therapeutics, Inc. (NASDAQ:STOK) Acquired by XTX Topco Ltd
XTX Topco Ltd purchased a new stake in Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) during the 1st quarter, HoldingsChannel reports. The fund purchased 40,181 shares of the company’s stock, valued at approximately $267,000. Other large investors have also recently bought and sold shares of the company. RTW Investments LP raised its position in Stoke […] - 2025-08-12 04:30:53
Brokerages Set Stoke Therapeutics, Inc. (NASDAQ:STOK) Target Price at $25.80
Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report) has received an average recommendation of “Buy” from the seven ratings firms that are currently covering the firm, Marketbeat Ratings reports. Five research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 1-year price […] - 2025-07-28 02:30:54
Stoke Therapeutics (NASDAQ:STOK) Shares Gap Up – Here’s What Happened
Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report) shares gapped up prior to trading on Friday . The stock had previously closed at $12.35, but opened at $12.93. Stoke Therapeutics shares last traded at $12.75, with a volume of 96,492 shares traded. Wall Street Analyst Weigh In A number of research analysts have recently weighed […] - 2025-07-20 05:22:59
Alps Advisors Inc. Sells 2,940 Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK)
Alps Advisors Inc. decreased its stake in shares of Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) by 6.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 39,890 shares of the company’s stock after selling 2,940 shares during the period. Alps Advisors Inc.’s holdings […] - 2025-07-18 05:21:01
Stoke Therapeutics, Inc. (NASDAQ:STOK) Given Consensus Rating of “Buy” by Brokerages
Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report) have been assigned an average recommendation of “Buy” from the seven analysts that are covering the firm, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average […] - 2025-06-30 02:34:50
Assenagon Asset Management S.A. Cuts Stake in Stoke Therapeutics, Inc. (NASDAQ:STOK)
Assenagon Asset Management S.A. lowered its position in shares of Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) by 29.0% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 959,603 shares of the company’s stock after selling 391,322 shares during the period. Assenagon Asset Management S.A.’s holdings in Stoke Therapeutics were worth $6,381,000 as of […] - 2025-06-15 05:44:52
Stoke Therapeutics, Inc. (NASDAQ:STOK) Shares Sold by BNP Paribas Financial Markets
BNP Paribas Financial Markets decreased its position in Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) by 94.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,422 shares of the company’s stock after selling 71,732 shares during the quarter. BNP Paribas Financial […] - 2025-06-04 05:14:48
Legal & General Group Plc Has $390,000 Stock Position in Stoke Therapeutics, Inc. (NASDAQ:STOK)
Legal & General Group Plc trimmed its position in Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) by 5.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 35,347 shares of the company’s stock after selling 2,139 shares during the quarter. Legal & General […] - 2025-05-01 04:42:53
Renaissance Technologies LLC Buys Shares of 129,043 Stoke Therapeutics, Inc. (NASDAQ:STOK)
Renaissance Technologies LLC purchased a new position in shares of Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 129,043 shares of the company’s stock, valued at approximately $1,423,000. Other large investors have […] - 2025-04-29 04:58:53
Stoke Therapeutics (NASDAQ:STOK) Receives “Buy” Rating from Needham & Company LLC
Stoke Therapeutics (NASDAQ:STOK – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at Needham & Company LLC in a research note issued to investors on Wednesday,Benzinga reports. They currently have a $22.00 price objective on the stock. Needham & Company LLC’s price objective suggests a potential upside of 237.42% from […] - 2025-04-11 04:46:50
HC Wainwright Reaffirms “Buy” Rating for Stoke Therapeutics (NASDAQ:STOK)
Stoke Therapeutics (NASDAQ:STOK – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at HC Wainwright in a research note issued to investors on Wednesday,Benzinga reports. They presently have a $47.00 price objective on the stock. HC Wainwright’s price target indicates a potential upside of 464.23% from the stock’s previous close. HC […] - 2025-03-21 04:25:10
Stoke Therapeutics (NASDAQ:STOK) Earns Buy Rating from Needham & Company LLC
Stoke Therapeutics (NASDAQ:STOK – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at Needham & Company LLC in a report released on Tuesday,Benzinga reports. They presently have a $22.00 target price on the stock. Needham & Company LLC’s price objective would indicate a potential upside of 166.34% from the stock’s […] - 2025-03-20 04:44:48
Brokerages Set Stoke Therapeutics, Inc. (NASDAQ:STOK) Target Price at $23.00
Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report) have earned an average rating of “Buy” from the ten ratings firms that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy […] - 2025-02-28 04:26:56
Stoke Therapeutics, Inc. (NASDAQ:STOK) Receives $21.29 Average Target Price from Brokerages
Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report) has earned an average recommendation of “Buy” from the ten analysts that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation, eight have issued a buy recommendation and one has issued a strong buy recommendation on the company. The […] - 2025-02-03 04:24:54

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc STOK holdings

DateNumber of STOK Shares HeldBase Market Value of STOK SharesLocal Market Value of STOK SharesChange in STOK Shares HeldChange in STOK Base ValueCurrent Price per STOK Share HeldPrevious Price per STOK Share Held
2025-12-11 (Thursday)21,014USD 695,353STOK holding decreased by -22275USD 695,3530USD -22,275 USD 33.09 USD 34.15
2025-12-10 (Wednesday)21,014USD 717,628STOK holding increased by 77331USD 717,6280USD 77,331 USD 34.15 USD 30.47
2025-12-09 (Tuesday)21,014USD 640,297STOK holding decreased by -53165USD 640,2970USD -53,165 USD 30.47 USD 33
2025-12-08 (Monday)21,014USD 693,462STOK holding increased by 44760USD 693,4620USD 44,760 USD 33 USD 30.87
2025-12-05 (Friday)21,014USD 648,702STOK holding decreased by -3783USD 648,7020USD -3,783 USD 30.87 USD 31.05
2025-12-04 (Thursday)21,014USD 652,485STOK holding increased by 1892USD 652,4850USD 1,892 USD 31.05 USD 30.96
2025-12-03 (Wednesday)21,014STOK holding decreased by -370USD 650,593STOK holding increased by 13136USD 650,593-370USD 13,136 USD 30.96 USD 29.81
2025-12-02 (Tuesday)21,384STOK holding increased by 148USD 637,457STOK holding decreased by -1534USD 637,457148USD -1,534 USD 29.81 USD 30.09
2025-12-01 (Monday)21,236USD 638,991STOK holding decreased by -17414USD 638,9910USD -17,414 USD 30.09 USD 30.91
2025-11-28 (Friday)21,236USD 656,405STOK holding decreased by -6371USD 656,4050USD -6,371 USD 30.91 USD 31.21
2025-11-27 (Thursday)21,236USD 662,776USD 662,7760USD 0 USD 31.21 USD 31.21
2025-11-26 (Wednesday)21,236USD 662,776STOK holding increased by 29518USD 662,7760USD 29,518 USD 31.21 USD 29.82
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of STOK by Blackrock for IE00B3VWM098

Show aggregate share trades of STOK

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-03SELL-370 30.960* 14.14 Profit of 5,232 on sale
2025-12-02BUY148 29.810* 14.07
2025-11-25SELL-222 29.820* 13.67 Profit of 3,034 on sale
2025-11-24BUY15,067 30.340* 13.59
2025-11-17SELL-231 26.950* 13.22 Profit of 3,054 on sale
2025-11-12SELL-21 25.130* 13.03 Profit of 274 on sale
2025-11-06SELL-21 22.470* 12.82 Profit of 269 on sale
2025-11-05SELL-21023.06020.320 20.594USD -4,325 12.77 Loss of -1,644 on sale
2025-11-04SELL-42 25.340* 12.70 Profit of 533 on sale
2025-11-03SELL-4229.38024.500 24.988USD -1,049 12.63 Loss of -519 on sale
2025-10-28BUY6331.63033.130 32.980USD 2,078 12.23
2025-10-24SELL-2132.28032.460 32.442USD -681 12.01 Loss of -429 on sale
2025-10-15BUY12635.60037.670 37.463USD 4,720 11.15
2025-10-02BUY2124.82024.830 24.829USD 521 10.99
2025-09-30BUY4223.50024.970 24.823USD 1,043 10.85
2025-09-11BUY8423.88024.000 23.988USD 2,015 10.47
2025-08-21SELL-2119.68019.700 19.698USD -414 10.42 Loss of -195 on sale
2025-07-31BUY6312.85012.950 12.940USD 815 10.35
2025-06-30SELL-4211.35011.690 11.656USD -490 10.10 Loss of -65 on sale
2025-06-25SELL-2111.81011.900 11.891USD -250 10.06 Loss of -38 on sale
2025-06-20SELL-4211.58011.960 11.922USD -501 10.03 Loss of -79 on sale
2025-05-23BUY219.3609.618 9.592USD 201 9.92
2025-05-19SELL-219.83010.190 10.154USD -213 9.92 Loss of -5 on sale
2025-05-15SELL-639.6309.660 9.657USD -608 9.93 Profit of 17 on sale
2025-05-12SELL-219.66010.130 10.083USD -212 9.95 Loss of -3 on sale
2025-05-09SELL-219.3609.600 9.576USD -201 9.95 Profit of 8 on sale
2025-04-30SELL-219.7609.880 9.868USD -207 9.99 Profit of 3 on sale
2025-04-24SELL-429.8809.900 9.898USD -416 10.01 Profit of 5 on sale
2025-04-17SELL-217.6907.720 7.717USD -162 10.08 Profit of 50 on sale
2025-04-15SELL-637.7507.990 7.966USD -502 10.14 Profit of 137 on sale
2025-04-14SELL-637.5607.690 7.677USD -484 10.17 Profit of 157 on sale
2025-04-09SELL-846.4306.470 6.466USD -543 10.28 Profit of 321 on sale
2025-04-07SELL-1476.0106.170 6.154USD -905 10.38 Profit of 622 on sale
2025-04-04SELL-2105.9406.200 6.174USD -1,297 10.43 Profit of 895 on sale
2025-03-31BUY216.6507.080 7.037USD 148 10.58
2025-03-19SELL-428.2608.950 8.881USD -373 10.87 Profit of 83 on sale
2025-03-14SELL-1268.6008.715 8.704USD -1,097 10.95 Profit of 283 on sale
2025-03-13SELL-428.1108.609 8.559USD -359 10.99 Profit of 102 on sale
2025-03-12SELL-7148.5208.590 8.583USD -6,128 11.03 Profit of 1,746 on sale
2025-03-07SELL-428.0108.210 8.190USD -344 11.16 Profit of 125 on sale
2025-03-06SELL-638.1508.190 8.186USD -516 11.21 Profit of 190 on sale
2025-03-03SELL-217.4007.930 7.877USD -165 11.37 Profit of 73 on sale
2025-02-28SELL-1267.8508.134 8.106USD -1,021 11.43 Profit of 419 on sale
2025-02-26SELL-218.2708.368 8.358USD -176 11.54 Profit of 67 on sale
2025-02-25SELL-638.2508.630 8.592USD -541 11.60 Profit of 189 on sale
2025-02-18BUY1059.71011.110 10.970USD 1,152 11.89
2025-02-13BUY2110.63010.640 10.639USD 223 11.97
2025-02-12BUY2110.26010.350 10.341USD 217 12.00
2025-02-11BUY6310.32010.360 10.356USD 652 12.04
2025-02-06BUY18912.74012.820 12.812USD 2,421 12.07
2025-01-27BUY2110.57011.110 11.056USD 232 12.25
2024-12-30BUY10510.80011.090 11.061USD 1,161 12.42
2024-12-06BUY8413.27013.450 13.432USD 1,128 12.32
2024-12-05BUY2112.57012.740 12.723USD 267 12.31
2024-12-04BUY10512.81013.500 13.431USD 1,410 12.29
2024-11-29BUY10512.11012.270 12.254USD 1,287 12.34
2024-11-27BUY8411.91012.000 11.991USD 1,007 12.38
2024-11-26BUY2111.77012.050 12.022USD 252 12.41
2024-11-21BUY10511.27011.730 11.684USD 1,227 12.55
2024-11-20BUY6311.31011.635 11.603USD 731 12.62
2024-11-18BUY25211.88012.600 12.528USD 3,157 12.73
2024-11-12BUY16813.62013.770 13.755USD 2,311 12.67
2024-11-08BUY10513.88013.945 13.938USD 1,464 12.59
2024-11-07BUY31513.27013.750 13.702USD 4,316 12.53
2024-11-06BUY4213.25013.810 13.754USD 578 12.47
2024-10-31BUY2112.36012.440 12.432USD 261 12.29
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of STOK

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19262,760120369,78171.1%
2025-09-18345,5786,230402,47485.9%
2025-09-17259,7730416,70362.3%
2025-09-1682,9520261,95131.7%
2025-09-15127,587993276,30546.2%
2025-09-12255,2623,603365,37569.9%
2025-09-11300,1678,555440,70568.1%
2025-09-10353,4000484,10973.0%
2025-09-09183,646100292,15362.9%
2025-09-08329,7980585,23356.4%
2025-09-0598,13410194,32450.5%
2025-09-04122,399505235,77751.9%
2025-09-03222,50523315,41070.5%
2025-09-02258,382703412,06662.7%
2025-08-29160,764424219,70673.2%
2025-08-28149,0550220,19767.7%
2025-08-27116,27613,373208,15555.9%
2025-08-26389,100479772,80250.3%
2025-08-25120,6871,219207,75158.1%
2025-08-22132,5257,377305,66343.4%
2025-08-21183,4770320,42957.3%
2025-08-20177,4771,472319,66355.5%
2025-08-19233,847443570,00341.0%
2025-08-18266,1572,972393,81367.6%
2025-08-15325,62013,531744,11343.8%
2025-08-14465,5641,736679,94268.5%
2025-08-13689,3761271,184,97858.2%
2025-08-1291,2160155,56358.6%
2025-08-1166,96539112,39059.6%
2025-08-0882,3620126,44965.1%
2025-08-0787,29121136,04964.2%
2025-08-06212,281190318,90566.6%
2025-08-0589,2490120,25074.2%
2025-08-04100,9230144,55069.8%
2025-08-0187,6550133,69665.6%
2025-07-31101,6910146,68669.3%
2025-07-3087,8570136,03064.6%
2025-07-29120,439100375,06732.1%
2025-07-28151,5713,048240,59063.0%
2025-07-25168,1821,866331,95850.7%
2025-07-24248,649116499,35049.8%
2025-07-23401,88419652,14661.6%
2025-07-22581,2472921,255,40446.3%
2025-07-21177,2620270,20565.6%
2025-07-18428,1310678,55063.1%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy